Host-Pathogen Interactions in a Cystic Fibrosis Polymicrobial Infection Model
Project Number5F31HL172440-02
Contact PI/Project LeaderCHARPENTIER, LILY
Awardee OrganizationDARTMOUTH COLLEGE
Description
Abstract Text
ABSTRACT
Cystic fibrosis (CF) is characterized by the formation of thick mucus in the lung leading to chronic
infection of various pathogens that are prone to developing antibiotic tolerance. Despite effective
modulator therapy (HEMT) that improves lung function and many clinical outcomes, HEMT does
not eliminate chronic, antibiotic-tolerant lung infections, the major cause of morbidity and mortality
in CF. Although most people with CF (pwCF) have multispecies lung infections, almost all
published studies focus on single-species infection models. Thus, polymicrobial-host interactions
in CF are not completely understood, especially under physiologically relevant conditions such as
anoxia typical of mucus plugs.
The overarching goal of our work is to use in vitro models to gain insight into how polymicrobial
infections develop in pwCF. Bacterial pathogens have been shown to secrete membrane vesicles
(bEVs) that diffuse through the CF mucus to deliver virulence factors such as DNA, RNA, and
proteins to their targets. As recent studies have shown that the first exposure to bacterial products
alters DNA methylation and gene silencing that affect subsequent exposures, our hypothesis is
that pwCF develop chronic infections in part due to epigenetic changes caused by preexposure
to CF pathogens that reduce the HBEC immune response to infection over time. This application
aims to characterize the effects of an in vitro model of CF polymicrobial infection on human
bronchial epithelial cells (HBEC) with preexposure to bEVs secreted by the common CF pathogen
Staphylococcus aureus. The polymicrobial culture contains four prevalent and abundant CF
pathogens: Pseudomonas aeruginosa, S. aureus, Streptococcus sanguinis, and Prevotella
melanogenica. Using transcriptomic and proteomic analysis, cytokine analysis, ATAC-Seq, and
DNA methylation analysis, this study aims to elucidate the host HBEC response to treatment with
bEVs. This study will contribute to our understanding of host-pathogen interactions in the CF lung
and potentially identify novel therapeutic targets during infection.
This project will provide the applicant with a broad range of both bioinformatic and lab techniques
that will provide a strong foundation for her long-term goal of becoming an academic researcher.
Public Health Relevance Statement
PROJECT NARRATIVE
Cystic fibrosis (CF) affects more than 100,000 people worldwide and causes the formation of thick mucus in
the lungs, leading to the chronic infection of various pathogens that are prone to developing antibiotic
tolerance. This application proposes that preexposure to bacterial extracellular vesicles leads to epigenetic
changes in host bronchial epithelial cells that alter the host immune response, contributing to the establishment
of chronic lung infections. The project will serve as a foundation for the candidate to develop skills as an
academic researcher and could lead to the development of novel therapeutic treatments for CF.
No Sub Projects information available for 5F31HL172440-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F31HL172440-02
Patents
No Patents information available for 5F31HL172440-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F31HL172440-02
Clinical Studies
No Clinical Studies information available for 5F31HL172440-02
News and More
Related News Releases
No news release information available for 5F31HL172440-02
History
No Historical information available for 5F31HL172440-02
Similar Projects
No Similar Projects information available for 5F31HL172440-02